Autopsy report · NCT04162145

BRIDGE Device for Treatment of Opioid Withdrawal

“Due to COVID-19 pandemic”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 7 months before it stopped.
• 12 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

BrightView LLC

Sponsor type

Industry

Conditions

Opioid Withdrawal; Pain; Craving

Interventions

Active BRIDGE device placement; Inactive BRIDGE device placement

Participants

12

Sites

2

Countries

United States

Trials that died the same way

• Microbiological Evaluation of Single Versus Multiple Visits Regeneration Using MALDI-TOF Mass Spectrometry
  “due to the COVID-19 pandemic” (99% match in meaning)
• Prevalence and Impact on QoL From Ototoxicity in Cancer Survivors
  “due to COVID-19” (93% match in meaning)
• Yogurt Supplementation to Alter Bone Biomarkers, the Gut Microbiota and Inflammation in Older Adults
  “Due to the onset of the COVID-19 pandemic” (90% match in meaning)
• Virtual Reality for the Treatment of Chronic Low Back Pain
  “Due to the impact of COVID-19” (90% match in meaning)
• Effect of Global Postural Re-education in Idiopathic Scoliosis
  “Because of the COVID-19 pandemic” (90% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.